Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts
Clinical trial NCT07139106 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07139106
- Sponsor
- New York State Psychiatric Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.